Monogenic diabetes: a gateway to precision medicine in diabetes

Haichen Zhang; Kevin Colclough; Anna L. Gloyn; Toni I. Pollin

doi:10.1172/jci142244

journal article Feb 01, 2021

Monogenic diabetes: a gateway to precision medicine in diabetes

Haichen Zhang

Kevin Colclough Anna L. Gloyn

Toni I. Pollin

Journal of Clinical Investigation Vol. 131 No. 3 · American Society for Clinical Investigation

View at Publisher Save 10.1172/jci142244

Topics

No keywords indexed for this article. Browse by subject →

References

202

[1]

Hattersley "ISPAD clinical practice consensus guidelines 2018: the diagnosis and management of monogenic diabetes in children and adolescents" Pediatr Diabetes (2018) 10.1111/pedi.12772

[2]

American Diabetes Association "2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2020" Diabetes Care (2020) 10.2337/dc20-s002

[3]

Tattersall "Mild familial diabetes with dominant inheritance" Q J Med (1974)

[4]

10.2337/diab.27.11.1112

[5]

[6]

10.2337/db16-0628

[7]

10.1001/jama.2014.6511

[8]

10.2337/db09-0555

[9]

10.1038/gim.2017.150

[10]

Laver T, et al. Redefining the pathogenicity of Maturity Onset Diabetes of the Young (MODY) genes: BLK, PAX4 and KLF11 do not cause MODY. Paper presented at: Diabetes UK Professional Conference 2018; March 14–16, 2018; London ExCeL, London, UK. https://doi.org/10.1111/dme.2_13570 Accessed Jan 8, 2020 10.1111/dme.2_13570

[11]

10.1038/s41467-017-00895-9

[12]

Thanabalasingham "Diagnosis and management of maturity onset diabetes of the young (MODY)" BMJ (2011) 10.1136/bmj.d6044

[13]

10.1038/ncpendmet0778

[14]

Prevalence of Vascular Complications Among Patients With Glucokinase Mutations and Prolonged, Mild Hyperglycemia

Anna M. Steele, Beverley M. Shields, Kirsty J. Wensley et al.

JAMA 10.1001/jama.2013.283980

[15]

10.1172/jci121994

[16]

10.1002/humu.22279

[17]

Macrosomia and Hyperinsulinaemic Hypoglycaemia in Patients with Heterozygous Mutations in the HNF4A Gene

Ewan R Pearson, Sylvia F Boj, Anna M Steele et al.

PLoS Medicine 10.1371/journal.pmed.0040118

[18]

10.1016/j.ejmg.2020.103928

[19]

10.1111/j.1464-5491.2009.02690.x

[20]

10.1046/j.1464-5491.2000.00305.x

[21]

10.1016/s0140-6736(03)14571-0

[22]

10.1210/js.2019-00278

[23]

10.2337/dc20-0408

[24]

Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations.

M M Byrne, J Sturis, K Clément et al.

Journal of Clinical Investigation 10.1172/jci117064

[25]

10.1002/humu.21110

[26]

10.2337/dc13-2248

[27]

10.1007/s00592-016-0859-8

[28]

10.1007/s00125-013-3075-x

[29]

10.4274/jcrpe.4461

[30]

10.2337/dc09-0681

[31]

10.1055/s-0035-1559605

[32]

10.1038/953

[33]

10.1093/clinchem/hvaa104

[34]

10.1111/j.1464-5491.2012.03709.x

[35]

10.1016/j.diabet.2016.10.003

[36]

10.2337/dc16-2462

[37]

10.1016/j.kint.2016.03.027

[38]

10.1074/jbc.274.19.12975

[39]

A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta

T. Lindner

Human Molecular Genetics 10.1093/hmg/8.11.2001

[40]

10.1007/s00125-011-2319-x

[41]

10.1371/journal.pone.0037423

[42]

10.1016/j.ajhg.2015.05.011

[43]

10.2337/db13-1784

[44]

Polak "Neonatal diabetes mellitus: a disease linked to multiple mechanisms" Orphanet J Rare Dis (2007) 10.1186/1750-1172-2-12

[45]

10.1210/er.2007-0029

[46]

10.1016/s2213-8587(13)70059-7

[47]

10.1007/s00592-011-0331-8

[48]

10.1007/s00125-009-1416-6

[49]

10.1007/s11154-010-9150-4

[50]

10.1056/nejmoa032922

Showing 50 of 202 references

Cited By

164

Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans

Isaac T. W. Harley, Kristen Allison · 2022

Frontiers in Immunology

Metrics

164

Citations

202

References

Details

Published: Feb 01, 2021
Vol/Issue: 131(3)

Authors

H

Haichen Zhang

Department of Clinical Laboratory, Shanghai Xuhui Central Hospital, Shanghai, China

K

Kevin Colclough

Department of Molecular Genetics, Royal Devon and Exeter National Health Service Foundation Trust, Exeter, United Kingdom

A

Anna L. Gloyn

Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, U.K.; National Institute for Health Research Oxford Biomedical Research Centre, The Churchill Hospital, Oxford, U.K.

T

Toni I. Pollin

Cite This Article

Haichen Zhang, Kevin Colclough, Anna L. Gloyn, et al. (2021). Monogenic diabetes: a gateway to precision medicine in diabetes. Journal of Clinical Investigation, 131(3). https://doi.org/10.1172/jci142244

Monogenic diabetes: a gateway to precision medicine in diabetes

You May Also Like